Canada’s National Advisory Committee on Immunization is expected to recommend today a pause in the use of the AstraZeneca-Oxford COVID-19 vaccine on those under the age of 55 because of safety concerns, sources tell CBC News.
Immunization committee to recommend provinces suspend AstraZeneca use among those under 55: sources
